USA - NASDAQ:SKIN - US88331L1089 - Common Stock
The current stock price of SKIN is 1.39 USD. In the past month the price decreased by -29.44%. In the past year, price decreased by -15.76%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.92 | 153.66B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 68.11 | 36.81B | ||
| KVUE | KENVUE INC | 14.02 | 28.79B | ||
| ELF | ELF BEAUTY INC | 38.62 | 6.97B | ||
| BRBR | BELLRING BRANDS INC | 15.23 | 4.16B | ||
| COTY | COTY INC-CL A | 18.82 | 3.62B | ||
| IPAR | INTERPARFUMS INC | 18.85 | 3.10B | ||
| ODD | ODDITY TECH LTD-CL A | 21.47 | 2.63B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.63 | 914.80M | ||
| HLF | HERBALIFE LTD | 3.95 | 859.94M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 750.03M | ||
| OLPX | OLAPLEX HOLDINGS INC | 13.75 | 733.79M |
The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. The company is headquartered in Long Beach, California and currently employs 769 full-time employees. The company went IPO on 2020-02-10. The firm and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The company specializes in skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus, and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in nanoneedling and microneedling, where its products are designed to provide either a non-invasive (nanoneedling) or minimally invasive (microneedling) skin treatment to individuals. Keravive specializes in scalp health with its products that are designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles.
BEAUTY HEALTH CO/THE
2165 Spring Street
Long Beach CALIFORNIA 33139 US
CEO: Brenton L. Saunders
Employees: 769
Phone: 18006034996
The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. The company is headquartered in Long Beach, California and currently employs 769 full-time employees. The company went IPO on 2020-02-10. The firm and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The company specializes in skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus, and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in nanoneedling and microneedling, where its products are designed to provide either a non-invasive (nanoneedling) or minimally invasive (microneedling) skin treatment to individuals. Keravive specializes in scalp health with its products that are designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles.
The current stock price of SKIN is 1.39 USD. The price increased by 6.92% in the last trading session.
SKIN does not pay a dividend.
SKIN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
BEAUTY HEALTH CO/THE (SKIN) operates in the Consumer Staples sector and the Personal Care Products industry.
BEAUTY HEALTH CO/THE (SKIN) has a market capitalization of 176.29M USD. This makes SKIN a Micro Cap stock.
You can find the ownership structure of BEAUTY HEALTH CO/THE (SKIN) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to SKIN. The financial health of SKIN is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months SKIN reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS decreased by -1147.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.74% | ||
| ROE | -25.68% | ||
| Debt/Equity | 4.91 |
14 analysts have analysed SKIN and the average price target is 2.3 USD. This implies a price increase of 65.11% is expected in the next year compared to the current price of 1.39.
For the next year, analysts expect an EPS growth of 31.62% and a revenue growth -10.5% for SKIN